|
Year of Diagnosis |
Total | In Situ | Localized | Regional | Distant | Unknown | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number | Percent | Number | Percent | Number | Percent | Number | Percent | Number | Percent | ||
| 2016-2020 | 155 | 4 | 2.6 | 40 | 25.8 | 63 | 40.6 | 28 | 18.1 | 20 | 12.9 |
| 2015-2019 | 144 | 4 | 2.8 | 41 | 28.5 | 53 | 36.8 | 22 | 15.3 | 24 | 16.7 |
| 2014-2018 | 134 | 4 | 3.0 | 39 | 29.1 | 50 | 37.3 | 18 | 13.4 | 23 | 17.2 |
| 2013-2017 | 135 | 4 | 3.0 | 41 | 30.4 | 43 | 31.9 | 23 | 17.0 | 24 | 17.8 |
| 2012-2016 | 137 | 4 | 2.9 | 41 | 29.9 | 44 | 32.1 | 24 | 17.5 | 24 | 17.5 |
| 2011-2015 | 132 | 1 | 0.8 | 47 | 35.6 | 39 | 29.5 | 26 | 19.7 | 19 | 14.4 |
| 2010-2014 | 142 | 2 | 1.4 | 48 | 33.8 | 44 | 31.0 | 32 | 22.5 | 16 | 11.3 |
| 2009-2013 | 152 | 1 | 0.7 | 56 | 36.8 | 46 | 30.3 | 33 | 21.7 | 16 | 10.5 |
| 2008-2012 | 163 | 2 | 1.2 | 65 | 39.9 | 47 | 28.8 | 32 | 19.6 | 17 | 10.4 |
| 2007-2011 | 164 | 2 | 1.2 | 66 | 40.2 | 46 | 28.0 | 29 | 17.7 | 21 | 12.8 |
| 2006-2010 | 176 | 3 | 1.7 | 63 | 35.8 | 58 | 33.0 | 27 | 15.3 | 25 | 14.2 |
| 2005-2009 | 185 | 2 | 1.1 | 66 | 35.7 | 57 | 30.8 | 26 | 14.1 | 34 | 18.4 |
| 2004-2008 | 184 | 2 | 1.1 | 61 | 33.2 | 54 | 29.3 | 23 | 12.5 | 44 | 23.9 |
| 2003-2007 | 185 | 2 | 1.1 | 63 | 34.1 | 50 | 27.0 | 20 | 10.8 | 50 | 27.0 |
| 2002-2006 | 185 | 5 | 2.7 | 65 | 35.1 | 47 | 25.4 | 18 | 9.7 | 50 | 27.0 |
| 2001-2005 | 209 | 4 | 1.9 | 87 | 41.6 | 43 | 20.6 | 20 | 9.6 | 55 | 26.3 |
| 2000-2004 | 204 | 6 | 2.9 | 88 | 43.1 | 46 | 22.5 | 18 | 8.8 | 46 | 22.5 |
| 1999-2003 | 219 | 8 | 3.7 | 94 | 42.9 | 60 | 27.4 | 22 | 10.0 | 35 | 16.0 |
| 1998-2002 | 228 | 8 | 3.5 | 87 | 38.2 | 75 | 32.9 | 26 | 11.4 | 32 | 14.0 |
| 1997-2001 | 222 | 5 | 2.3 | 78 | 35.1 | 85 | 38.3 | 27 | 12.2 | 27 | 12.2 |
| 1996-2000 | 195 | 6 | 3.1 | 58 | 29.7 | 85 | 43.6 | 24 | 12.3 | 22 | 11.3 |
| 1995-1999 | 192 | 5 | 2.6 | 54 | 28.1 | 87 | 45.3 | 26 | 13.5 | 20 | 10.4 |
| 1994-1998 | 180 | 4 | 2.2 | 57 | 31.7 | 77 | 42.8 | 24 | 13.3 | 18 | 10.0 |
| 1993-1997 | 178 | 4 | 2.2 | 64 | 36.0 | 70 | 39.3 | 24 | 13.5 | 16 | 9.0 |
| 1992-1996 | 187 | 5 | 2.7 | 71 | 38.0 | 68 | 36.4 | 24 | 12.8 | 19 | 10.2 |
| 1991-1995 | 188 | 6 | 3.2 | 77 | 41.0 | 65 | 34.6 | 26 | 13.8 | 14 | 7.4 |
| 1990-1994 | 194 | 5 | 2.6 | 73 | 37.6 | 66 | 34.0 | 27 | 13.9 | 23 | 11.9 |
| 1989-1993 | 192 | 5 | 2.6 | 60 | 31.3 | 65 | 33.9 | 29 | 15.1 | 33 | 17.2 |
| 1988-1992 | 186 | 9 | 4.8 | 49 | 26.3 | 58 | 31.2 | 26 | 14.0 | 44 | 23.7 |
| 1987-1991 | 184 | 11 | 6.0 | 42 | 22.8 | 48 | 26.1 | 27 | 14.7 | 56 | 30.4 |
| 1986-1990 | 176 | 11 | 6.3 | 33 | 18.8 | 44 | 25.0 | 25 | 14.2 | 63 | 35.8 |
| 1985-1989 | 165 | 11 | 6.7 | 34 | 20.6 | 39 | 23.6 | 25 | 15.2 | 56 | 33.9 |
| Notes: |
|---|
|
In Situ Stage represents the presence of malignant cells within the cell group from which they arose, with no penetration of basement membrane of the tissue and no stromal invasion. |
| Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel. |
| Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes. |
| Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes. |
| COVID-19 Pandemic: In 2020, the highly publicized impact of the COVID-19 pandemic on health services and the consequential delays and reductions in cancer screening and diagnosis led to a decline in the 2020 incidence rates for most cancer sites. Because 2020 was a temporary, anomalous year, it can bias estimates such as cancer incidence trends. |
| Source : Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2022. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services. |
|
Last Updated : April 13, 2023 |